Location of Repository

DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)

By Nathali Kaushansky, Daniel M Altmann, Chella S David, Hans Lassmann and Avraham Ben-Nun
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3344688
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (1993). Adorini L: Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    2. (2005). al: A high-resolution linkagedisequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.
    3. (2000). Altmann DM: T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus. Immunology
    4. (2007). Antigen-specific therapy of multiple sclerosis: the longsought magic bullet. Neurotherapeutics
    5. (2010). Baranzini SE: Multiple sclerosis genetics–is the glass half full, or half empty? Nat Rev Neurol
    6. (2009). Ben-Nun A: Autoimmune spread to myelin is associated with experimental autoimmune encephalomyelitis induced by a neuronal protein, beta-synuclein.
    7. (2009). Ben-Nun A: HLA-DQB1*0602 determines disease susceptibility in a new “humanized” multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    8. (1998). Ben-Nun A: T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    9. (2004). Ben-Nun A: The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J Immunol
    10. (2007). BenNun A: Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues.
    11. (1992). Bodmer JG: HLA class II nucleotide sequences,
    12. (1992). C: HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles. Neurology
    13. (2008). C: HLADQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma.
    14. (1991). Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. Proc Natl Acad Sci USA
    15. (2005). CS: HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.
    16. (1993). DM: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell
    17. (2007). Ebers G: Multiple sclerosis: the environment and causation. Curr Opin Neurol
    18. (2009). Ebers GC: Epistasis among HLA-DRB1, HLADQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA
    19. (2008). Ebers GC: Genetic epidemiology: the use of old and new tools for multiple sclerosis. Trends Neurosci
    20. (2009). Ebers GC: Multiple sclerosis: major histocompatibility complexity and antigen presentation. Genome Med
    21. (2000). et al: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med
    22. (2008). et al: HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes
    23. (2004). et al: Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
    24. (2004). Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis.
    25. (2007). Fernandez y Fernandez O: Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients. Acta Neurol Scand
    26. (2011). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature
    27. (1998). Ghaderi A: HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
    28. (2008). Goverman JM: Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med
    29. (1994). Hafler DA: Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide.
    30. (1990). Hafler DA: T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature
    31. (1990). HF: Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    32. (2006). I: Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice.
    33. (2004). Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
    34. (2007). Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice.
    35. (2005). Immunology of multiple sclerosis. Annu Rev Immunol
    36. (2002). Kerlero de Rosbo N, Ben-Nun A: Multiantigen/multiepitopedirected immune-specific suppression of “complex autoimmune encephalomyelitis” by a novel protein product of a synthetic gene.
    37. (2000). Kerlero de Rosbo N, Ben-Nun A: T-cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2(b) and H-2(s) mice.
    38. (2010). Koning F: Celiac disease: how complicated can it get? Immunogenetics
    39. (2000). Kuchroo VK: Fulminant spontaneous autoimmunity of the central nervous system in mice Kaushansky et al.
    40. (1991). Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    41. (1988). MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics
    42. (1991). Mice lacking MHC class II molecules. Cell
    43. (2008). MP: Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis.
    44. (1996). Offner H: Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat Med
    45. (2010). Oksenberg JR: Multiple sclerosis genetics. Neurol Clin
    46. (2006). Oksenberg JR: The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron
    47. (1994). Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review. Neurochem Res
    48. (1999). SL: Genetic aspects of multiple sclerosis. Semin Neurol
    49. (2000). Tabira T: Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    50. (2008). The complex genetics of multiple sclerosis: pitfalls and prospects. Brain
    51. (1995). The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med
    52. (1997). Thorsby E, Vartdal F: The HLADQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer. Tissue Antigens
    53. (2004). Vandenbark AA: Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    54. (1992). YL: Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.